Physician profile
John G Wilson
NPI 1124291612
$469.32
in general payments reported to CMS, 2019-2025
10 companies · $78.03 in 2025
The $78.03 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $42.35 · 2021: $64.53 · 2022: $53.50 · 2023: $107 · 2024: $17.75 · 2025: $78.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $190.66 | 2019-2025 | Vivitrol |
| Indivior INC. | $49.96 | 2019 | |
| Uswm, LLC | $48.00 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.68 | 2023-2025 | Fruzaqla, Alunbrig |
| Foundation Medicine, INC. | $38.67 | 2023 | Foundationone Cdx |
| Antares Pharma, INC. | $32.71 | 2023-2024 | Xyosted, Nocdurna, Tlando |
| Bayer Healthcare Pharmaceuticals INC. | $21.72 | 2023 | |
| Azurity Pharmaceuticals, INC. | $17.30 | 2025 | Danziten |
| Orexo US, INC. | $14.23 | 2020 | |
| Braeburn INC. | $13.39 | 2023 | Brixadi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.